Related Experiment Videos
The effect of inhibiting brain thromboxane biosynthesis on pentylenetetrazole-induced seizure threshold
Abstract:
The effect of inhibiting endogenous brain thromboxane (TXB2) on pentylenetetrazole-induced seizures was studied using the thromboxane synthetase inhibitors OKY-1581 (20 mg/kg) and UK 38,485 (50 mg/kg). Both compounds selectively decreased (greater than 90%) TXB2 production in brain measured after 2 min of convulsive activity but had no effect on brain PGE2, PGF2 alpha, or 6-keto-PGF1 alpha. No effect of these agents on the tonic seizure threshold was observed, whereas 10 mg/kg ip indomethacin, an agent which inhibits both TXB2 and prostaglandin production, reduced the tonic seizure threshold from 78 +/- 2.6 mg/kg in controls to 62 +/- 3.7 mg/kg. Thus, this study concludes that the availability of TXB2 with convulsant activity is unlikely to be a factor in altering tonic seizure activity observed with indomethacin.
Insights
Inhibiting brain thromboxane (TXB2) did not affect pentylenetetrazole-induced seizures. This suggests TXB2 is unlikely to influence seizure activity when its production is blocked.
Area of Science:
- Neuropharmacology
- Biochemistry
Background:
- Thromboxane (TXB2) is a bioactive lipid implicated in various physiological and pathological processes.
- The role of endogenous brain TXB2 in seizure activity remains incompletely understood.
Purpose of the Study:
- To investigate the effect of inhibiting endogenous brain thromboxane (TXB2) on pentylenetetrazole-induced seizures.
- To determine if TXB2 availability contributes to altered seizure thresholds.
Main Methods:
- Utilized selective thromboxane synthetase inhibitors (OKY-1581 and UK 38,485) to block TXB2 production in the brain.
- Measured TXB2 and prostaglandin levels in brain tissue following pentylenetetrazole administration.
- Assessed the effect of inhibitors on the tonic seizure threshold.
Main Results:
- OKY-1581 and UK 38,485 significantly inhibited brain TXB2 production (>90%) without affecting other prostanoids.
- These selective inhibitors did not alter the tonic seizure threshold.
- Indomethacin, a non-selective inhibitor, reduced the tonic seizure threshold, indicating prostaglandin involvement.
Conclusions:
- The availability of endogenous brain TXB2 does not appear to be a significant factor in modulating pentylenetetrazole-induced seizure activity.
- Prostaglandin production may play a role in altering seizure thresholds, as suggested by indomethacin's effects.